查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1957148

視網膜剝離診斷市場－全球產業規模、佔有率、趨勢、機會、預測：按疾病類型、診斷方法、地區和競爭格局分類，2021-2031年

Retinal Detachment Diagnostic Market - Global Industry Size, Share, Trends, Opportunity, & Forecast, Segmented By Disease Type, By Diagnostics, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球視網膜剝離診斷市場預計將從 2025 年的 21.8 億美元成長到 2031 年的 30.1 億美元，複合年成長率為 5.52%。

此市場領域涵蓋用於區分神經感覺視網膜和視網膜色素上皮的醫學影像系統和診斷設備，特別是光學同調斷層掃描（OCT）和眼科超音波設備。推動該市場成長的主要因素是全球高度近視盛行率的上升和人口老化，這兩者都會顯著增加後玻璃體剝離和視網膜裂孔的風險。根據美國眼科學會（ARVO）發布的2025年數​​據，與近視相關的視網膜剝離影響約每10萬人中有7.8人，凸顯了便利、準確的診斷通訊協定的迫切需求。

市場概覽
預測期 2027-2031
市場規模：2025年 21.8億美元
市場規模：2031年 30.1億美元
複合年成長率：2026-2031年 5.52%
成長最快的細分市場 眼底照片
最大的市場 北美洲

然而，在資源匱乏的環境中部署先進的診斷成像基礎設施成本高昂，這成為市場擴張的一大障礙。現代診斷平台所需的大量資本投入限制了其在發展中地區的普及，也阻礙了其在患者數量最多的地區的市場滲透。這種經濟限制迫使許多醫療機構依賴人工檢查方法，阻礙了自動化診斷解決方案的廣泛應用，並減緩了新興經濟體的收入成長。

市場促進因素

將人工智慧 (AI) 應用於視網膜診斷篩檢正發揮變革性作用，提高了光學同調斷層掃描(OCT) 和眼底成像診斷的準確性，並能夠更早地識別視網膜剝離風險。 AI 演算法對於簡化臨床工作流程至關重要，尤其是在檢測人工檢查可能遺漏的細微視網膜裂孔和牽引性隆起方面。隨著醫療機構診斷能力的提升，這項技術的應用正在推動市場實現實際成長。例如，根據 OptoMed 於 2025 年 2 月發布的“2024 年 1 月至 12 月初步財務快報”，該公司第四季度設備收入成長了 149.3%，主要得益於市場對整合 AI 的攜帶式篩檢解決方案的需求。

同時，糖尿病視網膜病變和全身性疾病負擔的加重，持續推動市場擴張，因為代謝性疾病常誘發牽拉性視網膜剝離。大量需要長期照護的高風險患者凸顯了對玻璃體視網膜介面進行持續監測的迫切需求。根據 News-Medical.Net 2025 年 3 月報道，最新數據顯示，超過 30% 的糖尿病患者患有某種形式的糖尿病視網膜疾病，這造成了對定期診斷監測的巨大需求。這種疾病負擔正在推動整個眼科醫療保健領域的發展，愛爾康公司 2025 年 3 月發布的 2024 會計年度年度報告顯示，其手術業務部門的淨銷售額達到 55 億美元，這凸顯了依賴精準上游診斷的醫療保健生態系統的龐大規模。

市場挑戰

全球視網膜剝離診斷市場面臨的一大挑戰是部署現代影像基礎設施的高昂成本。光同調斷層掃瞄（OCT）和專用眼科超音波設備等診斷系統需要大量資金投入，這為資源有限的醫療機構設置了很高的進入門檻。在許多發展中地區，醫院預算捉襟見肘，迫使管理者優先考慮基本營運支出，而非購置自動化診斷平台。這種資金差距實際上將很大一部分潛在的全球基本客群排除在外，使得製造商難以進入臨床需求量最大的龐大市場。

因此，投資這些技術的難度限制了市場的地理擴張，並導致人們繼續依賴準確度較低的人工檢測方法。這種現代化進程的滯後減緩了老舊設備的更新換代，並限制了供應商的收入來源。根據國際防盲協會（IAPB）發布的《2025年報告》，需要71億美元才能在低收入和中等收入地區充分擴大包括篩檢在內的重點眼科干預措施。這一巨大的投資缺口凸顯了新興經濟體面臨的嚴峻經濟壓力，這些壓力直接阻礙了必要診斷技術的應用。

市場趨勢

存轉眼科網路的擴展正在從根本上改變我們的診斷方式，它將影像檢查與即時診斷分開。這種運作模式允許衛星診所的技術人員使用自動眼底攝影機和光同調斷層掃瞄）設備獲取視網膜掃描影像，然後將其傳輸給中心專家進行非同步審查。這種去中心化的生態系統對於擴大診斷範圍，涵蓋醫療資源匱乏、玻璃體視網膜專科醫生稀缺的地區至關重要，並且能夠有效地對有視網膜剝離風險的患者進行分診，防止視力喪失不可逆轉。隨著對這種互聯診斷基礎設施的依賴性不斷增強，對相容成像設備的需求也顯著成長。根據拓普康公司2025年5月發布的報告，該公司眼科業務部門的營收年增9.1%，達到843億日圓，主要得益於其篩檢業務和直銷通路的快速擴張。

同時，即時術中光學同調斷層掃描（iOCT）的引入實現了視網膜結構的即時可視化，加速了複雜視網膜剝離手術的進展。與傳統的術前影像不同，iOCT可在手術過程中為外科醫生提供關於神經感覺視網膜膜脫離和復位的即時高解析度回饋，顯著提升臨床決策能力並降低再次手術的可能性。這一趨勢表明，手術流程正朝著診斷和治療融合的一體化方向發展。這些技術的市場地位也反映在其財務表現上。根據卡爾蔡司醫療技術公司於2024年12月發布的2023/24年度報告，其眼科策略業務部門的收入達到15.892億歐元，其中近期收購視網膜手術專家DORC為其互聯手術和診斷技術組合貢獻了9,990萬歐元。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：全球視網膜剝離診斷市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 疾病類型（裂孔性視網膜剝離、滲出性視網膜剝離、漿液性或續發性視網膜剝離、牽拉性視網膜剝離）
    • 診斷方法（眼底照相、眼底鏡檢查、數位眼底攝影機、螢光造影等）
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章：北美視網膜剝離診斷市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國別分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲視網膜剝離診斷市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國別分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區視網膜剝離診斷市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國別分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲視網膜剝離診斷市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東與非洲：國別分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲視網膜剝離診斷市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國別分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進因素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 近期趨勢

第13章：全球視網膜剝離診斷市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的議價能力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Canon Medical Systems Corporation
  • Carl Zeiss Meditec Inc.
  • Revenio Group Corporation
  • Eyenuk Inc.
  • Essilor International SA
  • HealPros LLC
  • Millennium Surgical Corp.
  • ONL Therapeutics
  • Peek Vision Ltd
  • Parata Systems LLC

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 17567

The Global Retinal Detachment Diagnostic Market is projected to expand from a valuation of USD 2.18 Billion in 2025 to USD 3.01 Billion by 2031, reflecting a compound annual growth rate of 5.52%. This market sector encompasses medical imaging systems and examination devices, specifically optical coherence tomography and ocular ultrasound, which are used to identify the separation of the neurosensory retina from the retinal pigment epithelium. Growth is primarily fueled by the rising global prevalence of high myopia and an aging demographic, both of which significantly increase the risk of posterior vitreous detachment and retinal tears. Data published by the Association for Research in Vision and Ophthalmology in 2025 indicates that retinal detachment following myopia affects approximately 7.8 individuals per 100,000, underscoring the critical need for accessible and precise diagnostic protocols.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 2.18 Billion
Market Size 2031USD 3.01 Billion
CAGR 2026-20315.52%
Fastest Growing SegmentFundus Photography
Largest MarketNorth America

However, market expansion faces a substantial hurdle due to the high acquisition costs associated with advanced imaging infrastructure in resource-limited settings. The significant financial investment required for modern diagnostic platforms restricts their availability in developing regions, thereby limiting market penetration in areas where patient volume is often highest. This economic constraint compels many healthcare facilities to rely on manual examination methods, ultimately hindering the widespread adoption of automated diagnostic solutions and slowing revenue growth in emerging economies.

Market Driver

The integration of Artificial Intelligence in Retinal Diagnostic Screening serves as a transformative driver, improving the precision of optical coherence tomography and fundus imaging to identify detachment risks at an earlier stage. AI algorithms are becoming essential for streamlining clinical workflows, particularly in detecting subtle retinal tears or tractional elevations that manual examinations might miss. This technological adoption is generating tangible market growth as healthcare facilities upgrade their diagnostic capabilities; for instance, Optomed's 'Financial Statements Bulletin, January - December 2024', released in February 2025, reported a 149.3 percent revenue surge in their Devices segment during the fourth quarter, primarily driven by demand for AI-integrated handheld screening solutions.

Simultaneously, the escalating burden of diabetic retinopathy and systemic diseases acts as a relentless catalyst for market expansion, as metabolic disorders frequently precipitate tractional retinal detachment. The need for constant surveillance of the vitreoretinal interface is intensifying due to the sheer volume of at-risk patients requiring longitudinal care. According to News-Medical.Net in March 2025, recent data indicates that more than 30 percent of all patients with diabetes now possess some form of diabetic retinal disease, creating a massive requirement for regular diagnostic monitoring. This disease burden fuels the broader ophthalmic sector, as evidenced by Alcon's March 2025 '2024 Annual Report', which noted that their Surgical business generated $5.5 billion in net sales, underscoring the immense scale of the healthcare ecosystem relying on accurate upstream diagnostics.

Market Challenge

The primary challenge hampering the Global Retinal Detachment Diagnostic Market is the prohibitive acquisition cost associated with modern imaging infrastructure. Examination systems such as optical coherence tomography and specialized ocular ultrasound units require substantial capital expenditure, creating a formidable barrier to entry for healthcare facilities in resource-limited settings. In many developing regions, hospital budgets are severely constrained, forcing administrators to prioritize basic operational expenses over the procurement of automated diagnostic platforms. This financial disparity effectively excludes a large segment of the potential global customer base, preventing manufacturers from tapping into high-volume markets where the clinical need is often greatest.

Consequently, the inability to invest in these technologies restricts the market's geographic expansion and sustains a reliance on less accurate, manual examination methods. This lack of modernization slows the replacement cycle of legacy equipment and limits the revenue streams available to device vendors. According to the International Agency for the Prevention of Blindness in 2025, a funding requirement of $7.1 billion was identified to adequately scale priority eye care interventions, including screenings, across low- and middle-income regions. This significant investment gap highlights the acute economic pressures that directly block the widespread adoption of necessary diagnostic technologies in emerging economies.

Market Trends

The expansion of Store-and-Forward Tele-ophthalmology Networks is fundamentally reshaping diagnostics by decoupling image capture from immediate interpretation. This operational model enables technicians in satellite clinics to acquire retinal scans using automated fundus cameras or optical coherence tomography, which are then transmitted to centralized specialists for asynchronous review. This distributed ecosystem is crucial for extending diagnostic reach into underserved regions where vitreoretinal specialists are scarce, effectively triaging patients with potential detachments before vision loss becomes irreversible. The growing reliance on these connected diagnostic infrastructures is driving substantial demand for compatible imaging hardware; according to Topcon Corporation's May 2025 report, revenue for their Eye Care business unit increased by 9.1 percent year-on-year to 84.3 billion yen, fueled notably by the rapid expansion of their screening business and direct sales channels.

Concurrently, the implementation of Real-Time Intraoperative Optical Coherence Tomography (iOCT) is advancing complex detachment surgeries by providing live visualization of the retinal architecture. Unlike traditional pre-operative imaging, iOCT offers surgeons immediate, high-resolution feedback on membrane peeling and the re-apposition of the neurosensory retina during the procedure, significantly enhancing clinical decision-making and reducing the likelihood of re-operation. This trend represents a shift towards integrated surgical workflows where diagnostics and treatment converge. The market prioritization of these combined technologies is evident in financial performance; according to Carl Zeiss Meditec's 'Annual Report 2023/24' from December 2024, the Ophthalmology Strategic Business Unit generated revenue of €1,589.2 million, with the recent acquisition of the retinal surgical specialist DORC contributing €99.9 million to their portfolio of connected surgical and diagnostic technologies.

Key Market Players

  • Canon Medical Systems Corporation
  • Carl Zeiss Meditec Inc.
  • Revenio Group Corporation
  • Eyenuk Inc.
  • Essilor International SA
  • HealPros LLC
  • Millennium Surgical Corp.
  • ONL Therapeutics
  • Peek Vision Ltd
  • Parata Systems LLC

Report Scope

In this report, the Global Retinal Detachment Diagnostic Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Retinal Detachment Diagnostic Market, By Disease Type

  • Rhegmatogenous Retinal Detachment
  • Exudative
  • Serous or Secondary Retinal Detachment
  • Tractional Retinal Detachment

Retinal Detachment Diagnostic Market, By Diagnostics

  • Fundus Photography
  • Ophthalmoscopy
  • Digital Retinal Camera
  • Fluorescent Retinal Angiography
  • Others

Retinal Detachment Diagnostic Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Retinal Detachment Diagnostic Market.

Available Customizations:

Global Retinal Detachment Diagnostic Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Retinal Detachment Diagnostic Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Disease Type (Rhegmatogenous Retinal Detachment, Exudative, Serous or Secondary Retinal Detachment, Tractional Retinal Detachment)
    • 5.2.2. By Diagnostics (Fundus Photography, Ophthalmoscopy, Digital Retinal Camera, Fluorescent Retinal Angiography, Others)
    • 5.2.3. By Region
    • 5.2.4. By Company (2025)
  • 5.3. Market Map

6. North America Retinal Detachment Diagnostic Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Disease Type
    • 6.2.2. By Diagnostics
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Retinal Detachment Diagnostic Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Disease Type
        • 6.3.1.2.2. By Diagnostics
    • 6.3.2. Canada Retinal Detachment Diagnostic Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Disease Type
        • 6.3.2.2.2. By Diagnostics
    • 6.3.3. Mexico Retinal Detachment Diagnostic Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Disease Type
        • 6.3.3.2.2. By Diagnostics

7. Europe Retinal Detachment Diagnostic Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Disease Type
    • 7.2.2. By Diagnostics
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Retinal Detachment Diagnostic Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Disease Type
        • 7.3.1.2.2. By Diagnostics
    • 7.3.2. France Retinal Detachment Diagnostic Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Disease Type
        • 7.3.2.2.2. By Diagnostics
    • 7.3.3. United Kingdom Retinal Detachment Diagnostic Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Disease Type
        • 7.3.3.2.2. By Diagnostics
    • 7.3.4. Italy Retinal Detachment Diagnostic Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Disease Type
        • 7.3.4.2.2. By Diagnostics
    • 7.3.5. Spain Retinal Detachment Diagnostic Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Disease Type
        • 7.3.5.2.2. By Diagnostics

8. Asia Pacific Retinal Detachment Diagnostic Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Disease Type
    • 8.2.2. By Diagnostics
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Retinal Detachment Diagnostic Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Disease Type
        • 8.3.1.2.2. By Diagnostics
    • 8.3.2. India Retinal Detachment Diagnostic Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Disease Type
        • 8.3.2.2.2. By Diagnostics
    • 8.3.3. Japan Retinal Detachment Diagnostic Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Disease Type
        • 8.3.3.2.2. By Diagnostics
    • 8.3.4. South Korea Retinal Detachment Diagnostic Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Disease Type
        • 8.3.4.2.2. By Diagnostics
    • 8.3.5. Australia Retinal Detachment Diagnostic Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Disease Type
        • 8.3.5.2.2. By Diagnostics

9. Middle East & Africa Retinal Detachment Diagnostic Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Disease Type
    • 9.2.2. By Diagnostics
    • 9.2.3. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Retinal Detachment Diagnostic Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Disease Type
        • 9.3.1.2.2. By Diagnostics
    • 9.3.2. UAE Retinal Detachment Diagnostic Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Disease Type
        • 9.3.2.2.2. By Diagnostics
    • 9.3.3. South Africa Retinal Detachment Diagnostic Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Disease Type
        • 9.3.3.2.2. By Diagnostics

10. South America Retinal Detachment Diagnostic Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Disease Type
    • 10.2.2. By Diagnostics
    • 10.2.3. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Retinal Detachment Diagnostic Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Disease Type
        • 10.3.1.2.2. By Diagnostics
    • 10.3.2. Colombia Retinal Detachment Diagnostic Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Disease Type
        • 10.3.2.2.2. By Diagnostics
    • 10.3.3. Argentina Retinal Detachment Diagnostic Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Disease Type
        • 10.3.3.2.2. By Diagnostics

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Retinal Detachment Diagnostic Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Canon Medical Systems Corporation
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Carl Zeiss Meditec Inc.
  • 15.3. Revenio Group Corporation
  • 15.4. Eyenuk Inc.
  • 15.5. Essilor International SA
  • 15.6. HealPros LLC
  • 15.7. Millennium Surgical Corp.
  • 15.8. ONL Therapeutics
  • 15.9. Peek Vision Ltd
  • 15.10. Parata Systems LLC

16. Strategic Recommendations

17. About Us & Disclaimer